The Phase III study will commence this quarter. It was reconfirmed several weeks ago. Although Neurocrine has five drugs in the clinic right now, they are all in Phase II development. The market generally deeply discounts Phase II drugs. So, this year we move some of them to Phase III and the stock will begin to move back upward. The "Alpha" article claims that Elagolix approval alone is worth a billion dollars in market cap to Neurocrine.
This is a good time to buy in and wait.
Differences are what make the world go around. I am fine with you holding the opposite opinion on the future of Neurocrine. What I objected to was that you used rumors instead of fact to support your position. Fair?
Well Ochs, thank you, I am sorry if I offended you.
This does not change the short/long term wiew of NBIX - yours or mine.
You still see Elagolix as an extra $1B market cap for NBIX, I still see this dead, and Neurocrine bankrupt.
Well,you boys can duke it out,I'm out of this POS! I should've sold yesterday and bought CMG like I planned.While this dogrocket sits at 7 I'll be making money again.1,500 shares going up for sale!Good riddance,nice leadership running this s#$t company.
From Abbott's 8-K today.
Elagolix, a novel, first-in-class oral gonadotropin-releasing hormone (GnRH), is in development for the treatment of endometriosis-related pain and fibroids. Abbott is working in partnership with Neurocrine to finalize the Phase 3 study design in endometriosis and a Phase 2 study in uterine fibroids is underway.
Do you even realize that Abbott has taken complete control of Elagolix and Neurocrine is just a passenger? Do you realize if the stock goes to $2, that is below cash? I didn't think so as you never let facts, get in the way of your bashing agenda. You need to get a life.
tr444 never provides any facts to support his position. He claims he "heard" that Abbott is going to pull out from its partnership with Neurocrine, which is worth absolutely nothing. He is just spreading rumors, but to what end?
Sorry to hear that you lost money on this.
Neurocrine's partner on the drug is Abbott Labs, so they have more than enough resources on this for a greater chance of success. For those who don't know, the drug is an oral administration for Endometriosis, which is currently treated by injection only.
Please come back with another pathetic one liner with no real content. I look forward to it.